Rheumatoid arthritis

Size: px
Start display at page:

Download "Rheumatoid arthritis"

Transcription

1 1 P a g e Rheumatoid arthritis Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks flexible (synovial) joints, and it's the most common persistent inflammatory arthritis, occurring throughout the world and in all ethnic groups. Generally, all rheumatic diseases can be local diseases but generally, they have systemic involvement and RA is one of the common rheumatic diseases; at least, 1% of people worldwide are affected by RA. So, RA is a systemic disease, primarily presents as Arthritis -affecting the joints- so the main problem is arthritis & Other Organs can be involved. Etiology is not clear, probably Multifactorial [both genetic and environmental factors appear to be involved], but we know the mechanism of the disease [RA is characterized by infiltration of the synovial membrane with lymphocytes, plasma cells, and macrophages. CD4+ T cells play a central role by interacting with other cells in the synovium. Activated T cells stimulate B cells to produce immunoglobulins including RF, and macrophages to produce pro-inflammatory cytokines. These act on endothelium, synovial fibroblasts, bone cells and chondrocytes to promote swelling and congestion of the synovial membrane and destruction of bone, cartilages and soft tissue.] and because of that, we have more options for treatment. (TNF, il-1, 6 are important so they create drugs that block them) Diagnosis: - Typical clinical presentation [joint pain, swelling and stiffness affecting the small joints of hand, feet and wrist (without swelling, no Dx of RA)] - Rheumatoid factor presence or absence does not make or exclude diagnosis but positive RF means more extra-articular manifestations and more severe manifestations [because RF can form immune complexes within the joint and extra articular tissues, leading to vasculitis.]. In old days, we said that 70% of affected are RF positive and it was part of the criteria and now it s more important in the criteria than before. -

2 - You have to exclude other diseases that may mimic RA or cause arthritis (other than RA). ACR 1987 classification criteria for RA, the old criteria: 1- Morning stiffness lasting at least for 1 hour.* 2- Swelling in 3 or more joints.* 3- Swelling in hand small joints.* *These 4 must be present at least 6 weeks. 4- Symmetric joint swelling.* 5- Erosions or decalcification on X-ray of the hand [radiological changes]. 6- Rheumatoid nodules. 7- Abnormal serum rheumatoid factor. << This is the old criteria in the new one, the only 2 differences are: rheumatoid nodules are not present any more in the new criteria and they added anti-citrullinated protein antibody (ACPA). >> This is a normal joint, the joint is surrounded by a synovium, and it s the site of the inflammation; normally it consists of 1-2 cells thickness. With synovial inflammation, the thickness becomes hundreds of cells. In this case, the synovium will act as a tumor, it will invade the bone and the cartilage and destruct them and for that reason, the erosions in RA are lateral on the sides while the inside damage will be later. 2 P a g e

3 Constitutional Signs and symptoms of systemic RA: Fatigue, tiredness, weakness, weight loss, myalgia, excessive sweating, low grade fever, morning stiffness, lymphadenopathy. Those are general vague symptoms due to the generalized systemic inflammation. Laboratory features in RA: 1) Anemia*. 2) Eosinophilia*. 3) Thrombocytosis*. 4) Increased levels of alkaline phosphatase, Aspartate amino-transferase, and gammaglutamyl-transferase. 5) Decreased albumin and pre-albumin. 6) Elevated erythrocyte sedimentation rate [ESR]*. 7) Elevated C-reactive protein [CRP]* 8) Increase ferritin* (ferritin is considered as acute phase reactant; any patient with anemia & increased ferritin then think of chronic inflammatory disease). Now, the dr. had moved on to show us different pictures to patients with RA: 3 P a g e This looks normal once you look at it, but if you look more carefully, you see early changes in the MCPs & PIPs with symmetrical synovitis, no deformity Early RA with soft tissue swelling, involving PIPs Joints. Note that DIPs are spared and this is typical for RA.

4 This is severe disease, synovitis & Subluxation of MCPs, RA nodules. Again; DIPs are relatively spared. This is swan neck deformity (arrow) & boutonniere deformity (arrowhead). Maybe, you ll never see these deformities because of better treatment than before. This is ulnar deviation, damage of MCPs & PIPs & rheumatoid nodules & muscle atrophy. Ruptured tendon in RA patients The DIPs still relatively spared. 4 P a g e

5 This is metatarso-phalygeal [MTP] joint, it can be also affected. RA patient with carpal tunnel syndrome [CTS] There is distal involvement and it could be part of osteoarthritis. Deformity, subluxation, osteoporosis, erosions (MCP). This is a typical X-Ray where the carpal bones affected and damaged and soft tissue swelling around the MCPs (are damaged) and PIPs, osteoporosis. 5 P a g e

6 The dr. said that he ll not comment that much on the X-Ray but if you see X-Ray in the exam that shows ulnar deviation and damage on the MCP joint, it will be rheumatic Arthritis, there will be no another question about it. Here ulna styloid erosion, as I said it starts as erosion from sides, later on, it will be inside. Metatarsal joint, there could be damage or erosion (in 5 th MTP) and fibular deviation rather than ulnar deviation in the upper extremities. MTP joints with erosions, subluxation, osteopenia [a condition where bone mineral density is lower than normal. It is considered by many doctors to be a precursor to osteoporosis] Bone uptake in RA; carpal bones, MCPs and PIPs 6 P a g e

7 Differential Diagnosis: - Viral syndromes. - Post Streptococcal/other infections. - Psoriatic arthritis, reactive arthritis, and other systemic rheumatological diseases. - Crystal arthropathy like Gout. - Septic arthritis also may coexist. Here is Subcutaneous nodules. the typical site for it is the elbows, extensors, hands. * Rheumatoid nodules occur almost exclusively in seropositive patients, usually at sites of pressure or friction such as the extensor surfaces of the forearm [elbows], sacrum, Achilles tendon and toes. They may be complicated by ulceration and secondary infection. Similar nodules may occur in the pleura, lung, pericardium, and sclera. This slide is just to show you that this is a systemic disease that can affect even the heart, the lungs, kidneys (although it is not common), joint, skin and everywhere. 7 P a g e

8 Here we see lung nodules which is part of the disease. ILD [interstitial lung disease], Cavitation, TB, abscess, fungi, tumor, Nodule Major ocular manifestations: - Keratoconjunctivitis sicca. - Scleritis:painful and serious - Episcleritis; an inflammatory condition affecting the episcleral tissue that lies between the conjunctiva and the sclera, it's painful and may cause perforation. - Uveitis Episcleritis is common in RA, Superficial but cause irritation. Scleromalacia: degeneration and thinning (softening) of the sclera, occurring in rheumatoid arthritis, a potential serious complication is the perforation. Some patients got perforation and they lose vision (in the old days) but nowadays because of the immunosupression, this doesn t happen. 8 P a g e

9 Scleromalacia perforance: In this condition rheumatoid nodules may develop in the sclera and cause perforation And some patients their cornea may melt and they need corneal transplant [Marginal corneal disease, and perforation]. Rheumatoid vasculitis usually occurs in older seropositive patients in the context of systemic symptoms and multiple extra articular features. Vasculitis can vary from relatively benign nail-fold infarcts to widespread cutaneous ulceration and skin necrosis. Involvement of medium sized arteries can lead to mesenteric, renal or coronary artery occlusion. Vasculitis; blood vessels inflammation (here affecting small vessels) Vasculitis causes gangrene like this 9 P a g e

10 The spinal cord may affected because it has synovioum around the odontoid process and this synovioum may cause damage to the transverse ligament or to the odontoid, if it causes damage to the ligament, it will cut & cause compression on the spinal cord. Signs of SC damage: - Severe neck pain radiating to Occiput - Tingling or numbness in fingers and feet - Motor weakness - Urinary bladder dysfunction - Jumping legs <<< When the spinal cord is affected the patient may die! They take him to the surgery and the anesthetic resident don t know that he has RA and he push the patient backward with force so the patient has trans-sectional cord and he die on the table! >>> 10 P a g e

11 This is the new criteria, and you don t have to remember it. If you have more than 10 joints involvement then you have at least 1 small joint because this is a poly-articular arthritis affecting small and large joints, so if you have more than 10 joints and one of them is small joint then you say yes and go to the next step; the serology, if the serology is positive then this is definitely RA (serology means RF OR ACPC). If serology is negative then you look to the duration; if it is 6 weeks and more then it is RA. If it is shorter than 6 weeks then you go to APR (Acute Phase Reactant, CRP & ESR), If the APR positive then it is RA, if it is negative still not diagnosed. Most of the patient, the APR is positive and the serology: 75% is positive. 11 P a g e

12 The dr. didn t explain this table and it s not for memorization. The dr. said that the treatment is very complicated but the main action of drugs is that they block the inflammatory mediators (TNF, il 6, 2). And the earlier we diagnose and the earlier we treat, the higher percentage the person will go to remission. NAIDs are not good, they don t decrease the progression of the disease & nobody goes into remission. Prednisolone by itself don t make a difference (it increase CVS mortality) but if combined with disease modifying drugs [DMARDs], there s some evidence about increase the probability of remission. 12 P a g e

13 Systemic lupus erythromatosus SLE: is an Autoimmune multisystem disease characterized by widespread inflammation and production of autoantibodies (or autoimmune connective tissue disease) that can affect any part of the body. As occurs in other autoimmune diseases, the immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage. It is a Type III hypersensitivity reaction in which antibody-immune complexes precipitate and cause a further immune response. Even the RF will be positive in SLE (30% or more in SLE patients have RF positive and can present with RA and then you misdiagnose SLE as RA.). SLE is a systemic disease rather than local as RA, the difference is that: RA is a disease of joints with systemic manifestations while SLE is a true systemic disease and can mimic any disease including RA. So, this disease is associated with wide spectrum of presentation. Epidemiology: SLE is the most common connective tissue disease, the risk increases according to: 1) AGE: the peak of the age onset is between years old [20-30 in the book] because of complications as pregnancy, but it can affect any age. 2) SEX: around 90% of affected individuals are females. During the childbearing age, the ratio is 10:1. 3) RACE: high prevalence in African in US and UK 1: ,also in high prevalence in Latino and Asian.While rare in Africa. Caucasian prevalence 1:2000. The overall 5 years survival of SLE is 90%. And the mortality within 5 years of diagnosis occurs due to organ failure or overwhelming sepsis, both of which are modifiable by early effective intervention. >> The dr. said that he don t know the prevalence in Jordan and how much the problem is but this disease is a bad disease, there s no one year without losing few patients with lupus so it s associated with high mortality (young females) and morbidity. 13 P a g e

14 Clinical features 1) General Features: - Nonspecific symptoms: Severe fatigue, Fever, Weight loss, Anorexia, Lymphadenopathy. >> those are similar to the RA symptoms with 2 differences: - The fever is much higher in SLE while in RA; it s low-grade fever. - The typical presentation of SLE is much more than RA, where in RA (joint pain & swelling with morning stiffness), while in SLE (extreme fatigue, febrile, dyspnea, typical rashes on the face, etc). 2) Raynaud syndrome (secondary Raynaud's): is a vaso-spastic disorder causing discoloration of the fingers, toes, and occasionally other areas where it is caused by other instigating factor [ other than the ones causing primary Raynaud's], most commonly connective tissue disorders such as systemic lupus erythematous. 14 P a g e

15 3) Dermatological features: Malar rash: in 30-60%, it s an erythematous butterfly rash occurs over nasal bridge and malar bones [cheeks] and sparing the naso-labial fold. - It's erythematous, raised and painful or itchy. - When taking medication, it becomes faint. - It s superficial rash. Photosensitivity: rash over the sun exposed areas; [face, neck and V shaped area of chest]. - Rash varies in severity depending on exposure, Less under the orbit protected areas. - After they re exposed to sun for minutes, they come with sloughed skin - like rash Discoid rash: with erythematous hyper-pigmented margins and flat scarred hypo-pigmented centers. - This can be seen in SLE and pure cutaneous lupus. - It s a deep rash with scarring mainly on the face and neck. - Characterized by hyperkeratosis and follicular plugging and may cause scarring alopecia if presented on the scalp. 4) Gastrointestinal features: Oral ulcers: Oral or nasopharyngeal ulceration, usually painless, observed by physician Oral lesions in SLE: Erythema of hard and soft palate. Also you see papules, vesicles and petechiae. Also erythematous rash of the tongue. 15 P a g e

16 Mesenteric vacuities: is a serious complication which can present with abdominal pain, bowel infraction or perforation. 5) Arthritis and Arthralgia: Arthritis: Non-erosive arthritis involving 2 or more peripheral joints, characterized by tenderness, swelling, or effusion Symmetrical, but can be asymmetrical, affect large and small joints, it can be anything!! SLE arthropathy: Non erosive arthritis, Hand may show diffuse soft tissue swelling, ulnar deviation, swan neck deformity, MCP subluxation. In old days; 20 years ago, the rheumatology was only an observational specialty, there was no medications except methotrexate. So they was saying that the difference between RA & SLE arthritis that SLE is non-erosive (but not 100%!!) with deformities. Arthralgia: migratory arthralgia with early morning stiffness. tenosynovitis and small joint synovitis that can mimic RA. 6) Pulmonary features:: Pleuritis: the most common [30%] in life time of SLE patient. Pneumonitis, pulmonary embolism, pulmonary hypertension, pulmonary fibrosis & nodules Pulmonary hemorrhage: the most dreadful with 50 % mortality with treatment. Usually, males with SLE die because of pulmonary hemorrhage. < It can cause any disease in the lung > 16 P a g e

17 7) Cardiovascular features: Pericarditis: the most common. Aortic insufficiency: the most common valvular lesion (it damages the valves) Endocarditis, aortitis, myocarditis, valvulitis and antibiotic prophylaxis indicated for dental and surgical procedures Accelerated atherosclerosis & damage to the coronaries (CAD) with 10 times higher mortality from myocardial infarction from age and sex matched. Serositis: it includes: - Pleuritis: convincing history of pleuritic pain, pleural rub heard by a physician or evidence of pleural effusion, with dyspnea. OR - Pericarditis: documented by ECG, pericardial rub or evidence of pericardial effusion. < So, SLE can affect the pleura or inside the pleura > 8) Hematological features: Hemolytic anemia with reticulocytosis & mild jaundice & LDH >> usually, in hemorrhage, if the bone marrow still working, reticulocyte count will increase but if the bone marrow isn t working (aplastic crisis bcz of lupus), reticulocyte count will decrease. But in normal person, reticulocyte count will increase bcz the bone marrow will push more reticulocytes to the blood. Leukopenia: less than 4,000/mm total on 2 or more occasions OR Lymphopenia: less than 1,500/mm on 2 or more occasions OR Thrombocytopenia: less than 100,000/mm, in the absence of offending drugs. 9) Renal features: Lupus glomerulonephritis: presented as Persistent proteinuria (due to inflammation) greater than 0.5 grams per day or grater than 3+ or Cellular casts (due to glomerulonephritis as in children); may be red cell, hemoglobin, granular, tubular, or mixed. Impaired kidney function, as if creatinine level increases, then you should treat or the patient will develop renal failure. 17 P a g e

18 ** Lupus nephritis predict out come (prognosis); the kidneys are the target of lupus, if the kidney function is normal then the outcome is acceptable -except if there s other serious organ involvement- ** Major cause of mortality & morbidity. 10) Neurological features: Seizures OR psychosis: in the absence of offending drugs or known metabolic derangements; e.g., uremia, ketoacidosis, or electrolyte imbalance < So, the global function of the brain will be impaired > 11) Immunological disorders: 95% of lupus patients are Anti-Nuclear Antibody (ANA) positive, but this antibody isn t specific for SLE since many diseases can be ANA positive. (so ANA test is sensitive but not specific). More specific tests: 1- Anti-DsDNA antibody. or 2- Anti smith antibody. And/Or 3- An abnormal serum level of IgG or IgM anticardiolipin antibodies. Or 4- A positive test result for lupus anticoagulant using a standard method. ACR criteria; 1982 classification criteria: The diagnosis of SLE is based on a combination of clinical features and laboratory abnormalities. To fulfill the classical criteria of SLE, You must have 4 criteria of 11 [simultaneously or serially] from the flowing: Malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, serositis, renal disorder, neurological disorder, hematologic disorder, immunologic disorder, antinuclear antibody. 18 P a g e

19 Anti-phospholipid antibody syndrome [APS] It is an autoimmune, hyper-coagulable state caused by antibodies against cellmembrane phospholipids that provokes blood clots (thrombosis) in both arteries and veins as well as pregnancy-related complications such as miscarriage, stillbirth, preterm delivery, or severe preeclampsia. Can be: - Primary (50%) without underlying disease. - Secondary (50%) to SLE, malignancy or infection. For diagnosis, you need 1 clinical & 1 lab criteria; - Clinically: 1) Recurrent venous and arterial thrombosis. 2) OR/AND Recurrent fetal loss. - Labs: 1) Lupus anticoagulant test by mixing studies: those which interfere with phospholipid dependent coagulation tests. 2) OR Anti-Cardiolipin antibodies test: antibodies which bind to negatively chared phospholipids on an ELISA plate. Thrombocytopenia & prolonoged PTT are clinical findings but not part of the criteria. Labs in SLE >> ANA: 95% positive, sensitive but not specific. 5-10% positive general population, also positive in other auto immune diseases (eg. thyroiditis) >> Anti-DNA antibody: specific but not sensitive, increase with active disease % of patients are positive. >> Anti-smith antibody: specific for SLE. 30% are positive. >> Rheumatoid factor: can be positive in 30%. 19 P a g e

20 Depend on organ involved Leukopenia and lymphopenia are common Thrombocytopenia Anemia of chronic disease Hemolytic anemia with high reticulocyte count, coombs positive Proteinurea, casts Abnormal liver and kidney function RA (as polyarticular arthritis) Vs. SLE (as arthritis in a connective tissue disorder): - CBC: white count & platelets are increased & Hb in decreased in RA while in SLE, Hb, white count & platelets are down. - Hemolytic anemia: not significant in RA but common in SLE. Anemia in RA is mainly due to GI hemorrhage, due to medications as NSAID & steroids. - C-reactive protein: negative in lupus (except in infections) & positive in RA. Always remember that pregnancy & SLE are not friends!! Familial Mediterranean fever - This is the most common of the familial periodic fever, predominantly affecting the Middle East, south Europe. - Autosomal recessive (so you need 2 mutations) disease characterized by attacks of serositis and fever, attacks are acute and sudden (last from 6-96 hrs; few hours to days); it come and resolve alone or by NSAID. - First attack occur before age 20 in 90%. - Symptoms: Abdominal pain in 95%, mostly as acute abdomen and peritonitis but some times mild, Mono-arthritis with effusion in 75%, mostly knees, ankles or wrists, Chest pain/ pleuritis (unilateral)in 30%, Pericarditis (rare 1%) WITH fever - or may be fever alone-. - The main complication of this disease is amyloidosis; any chronic inflammation can end with amyloidosis as RA. So it s a chronic recurrent inflammation that ends with amyloidosis and the most sensitive organ to amyloidosis is the kidneys so they end up with dialysis. 20 P a g e

21 Genetics: the responsible gene has been located in short arm of chromosome 16, MEFV gene encodes protein (pyrin, marenostrin), Pyrin mostly in cytoplasm of neutrophils or monocytes /regulates inflammation [regulates neutrophil mediated inflammation by indirectly suppressing the production of IL-1]. >> mutations: 28 mutation (most common), M694V and V726A. >> M694V associated with more severe disease and higher risk of amyloidosis Treatment: Colchicine (1-2 mg QD); decrease 60% of attacks and modifies 20-30% & prevents amyloidosis. It arrests cell division in the microtubules so decrease the inflammation. NSAIDs may help abort attack. THE END Best of luck ALL da3watkom :D Done by: Sara AL-Zu'bi & Hadeel Al-Kofahi. 21 P a g e

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling

More information

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he LIVING WITH SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. Rowan Diagnostic Clinic Salisbury, N.C. May 11, 2013 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement

More information

High Impact Rheumatology

High Impact Rheumatology High Impact Rheumatology Systemic Lupus Erythematosus Bernard Rubin, DO MPH Case 1: History A 45-year-old woman presents with severe dyspnea and cough. She was in excellent health until 4 weeks ago when

More information

When is it Rheumatoid Arthritis When to Refer

When is it Rheumatoid Arthritis When to Refer When is it Rheumatoid Arthritis When to Refer Nancy A. Brown, DO Spring 2015 When is it Rheumatoid Arthritis When to Refer Learning objectives To review the definition and epidemiology of Rheumatoid Arthritis

More information

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS LUPUS 101 LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS SLE SUBSETS SUBACUTE CUTANEOUS LUPUS DRUG INDUCED LUPUS NEONATAL LUPUS LATE ONSET LUPUS ANTI-PHOSPHOLIPID

More information

Rheumatoid arthritis

Rheumatoid arthritis Rheumatoid arthritis 1 Definition Rheumatoid arthritis is one of the most common inflammatory disorders affecting the population worldwide. It is a systemic inflammatory disease which affects not only

More information

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. October 20, 2012 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement Diagnosis Treatment Pregnancy

More information

Pharmaceutical pathology

Pharmaceutical pathology Pharmaceutical pathology Livia Vida 2018 1. Necrosis, types, examples. Apoptosis. 2. Adaptations I. Degeneration, atrophy. 3. Adaptations II. Hypertrophy, hyperplasia. 4. Pigments. Calcification. 5. Inflammation

More information

FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD

FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD FMF Is a hereditary autoinflammatory disease caused by mutations in Mediterranean fever gene (MEFV). It is inherited in an autosomal recessive

More information

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010 Objectives Rheumatology for the Primary MD (Not just your grandmother s disease) Identify when it is appropriate to refer for rheumatologic evaluation Autoimmune/ Inflammatory v. noninflammatory disease

More information

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases

More information

Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011

Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 Rheumatoid Arthritis Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 The security of experience. The power of innovation. www.rgare.com Case Study

More information

Inflammatory rheumatic diseases

Inflammatory rheumatic diseases Learning objectives Inflammatory rheumatic diseases Bruce Kidd Barts & The London, Queen Mary, University of London To understand: 1. prevalence and range of the rheumatological s 2. clinical features

More information

Living with Lupus: An Insider s Perspective

Living with Lupus: An Insider s Perspective Living with Lupus: An Insider s Perspective Pamela Thorpe, MD, FACP Lupus Foundation of America, Inc. Philadelphia Tri-State Chapter Volunteer May 2014 My Own Story Is it Lupus Yet? The What What is this?

More information

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic SLIDE 3: Introduction to autoimmune diseases Chronic Autoimmune diseases Sometimes relapsing : and remitting. which means that they present as attacks Progressive damage Epitope spreading more and more

More information

Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018

Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018 Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018 No Disclosures Objectives Recognize early signs of RA/PsA what to

More information

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist Case presentations Related to some Rheumatic Diseases Lab & Clinic i Programs, Tuesday, April 24, 2012 COORDINATOR: Dr M. Mahdi Mohammadi, LMD,PhD, Immunologist COORDINATOR: Dr M. Mahdi Mohammadi, LMD,PhD,

More information

Juvenile Chronic Arthritis

Juvenile Chronic Arthritis Juvenile Chronic Arthritis Dr. Christa Visser MBChB MMed (Med Phys) Diploma Musculoskeletal Medicine (UK), Member Society of Orthopaedic Medicine (UK) Childhood Arthritis JCA/JIA/JRA Remember Acute rheumatic

More information

A CRP B FBC C LFT D blood culture E uric acid

A CRP B FBC C LFT D blood culture E uric acid 1 A 39 year old lady with rheumatoid arthritis is admitted to hospital with a hot, swollen and painful right knee. Which is the most important blood test? A CRP B FBC C LFT D blood culture E uric acid

More information

MANAGING THE PATIENT WITH POSITIVE ANA

MANAGING THE PATIENT WITH POSITIVE ANA MANAGING THE PATIENT WITH POSITIVE ANA Rafael F. Rivas-Chacon, M.D. Disclosures Grant/Research support for: Pfizer Study JIA A3921104 Tofacitinib not related to this presentation 1 Positive Antinuclear

More information

LUPUS (SLE) MEDICAL SOURCE STATEMENT

LUPUS (SLE) MEDICAL SOURCE STATEMENT LUPUS (SLE) MEDICAL SOURCE STATEMENT From: Re: (Name of Patient) (Social Security No.) Please answer the following questions concerning your patient s impairments. Attach relevant treatment notes, radiologist

More information

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of

More information

Patient with Musculo-skeletal Complaints - Summary

Patient with Musculo-skeletal Complaints - Summary Patient with Musculo-skeletal Complaints - Summary 1. Soft Tissue Rheumatism or Arthritis 2. Arthritis Monoarticular Polyarticular - :- (Asymmetrical) (Symetrical) :- -Crystals, Gout - Infective acute

More information

.,Dr Ali Alkazzaz Babylon collage of medicine 2016

.,Dr Ali Alkazzaz Babylon collage of medicine 2016 .,Dr Ali Alkazzaz Babylon collage of medicine 2016 Lupus history Lupus is the Latin word for wolf 1 st used medically in the 10 th century Described clinically in the 19 th century Butterfly rash in 1845

More information

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Belimumab Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date... 11/15/2017 Next

More information

AOS 3: Rheumatoid Arthritis

AOS 3: Rheumatoid Arthritis AOS 3: Rheumatoid Arthritis Arthritis (General) = inflamed joint - NOT a single disease: covers >100 types - Involves disability + decreased quality of life o Can also occur in young people (not just the

More information

Insights into the DX of Pediatric SLE

Insights into the DX of Pediatric SLE Insights into the DX of Pediatric SLE Dr. John H. Yost Pediatric Rheumatology Children s Hospital at Dartmouth Assistant Professor of Medicine Geisel School of Medicine at Dartmouth john.h.yost@hitchcock.org

More information

Types of osteoarthritis

Types of osteoarthritis ARTHRITIS Osteoarthritis is a degenerative joint disease is the most common joint disorder. It is a frequent part of aging and is an important cause of physical disability in persons older than 65 years

More information

APPROACH TO PATIENTS WITH POLYARTHRALGIA

APPROACH TO PATIENTS WITH POLYARTHRALGIA APPROACH TO PATIENTS WITH POLYARTHRALGIA Scott Vogelgesang, MD Division of Immunology University of Iowa No conflicts of interest DEFINITIONS Arthralgia joint pain with no evidence of inflammation Arthritis

More information

Rheumatology Cases for the Internist

Rheumatology Cases for the Internist Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School

More information

Familial Mediterranean Fever. By:Ismaeel Qattam

Familial Mediterranean Fever. By:Ismaeel Qattam Familial Mediterranean Fever By:Ismaeel Qattam FMF : It s characterized by auto inflammatory condition that causes recurrent fevers and painful inflammation of the abdomen, lungs, joints, etc. It s an

More information

Understanding Rheumatoid Arthritis

Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result

More information

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 1 Other Types of Lupus Discoid Lupus Erythematosus Lupus Pernio --- Sarcoidosis Lupus Vulgaris --- Tuberculosis of the face Manifestations of SLE Fever Rashes Arthritis

More information

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis Office Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Drs. Cassell and Boren Eugene, OR 541-687-0816 mderlacki@comcast.net No financial relationships to disclose Rheumatoid Arthritis 1% of

More information

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Systemic Lupus Erythematosus Marc C. Hochberg, MD, MPH Professor of Medicine and Head, Division of Rheumatology University of Maryland School of Medicine CASE: HISTORY A 26-year-old woman is seen for migratory

More information

Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience

Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience Ala M. AlHeresh MD* ABSTRACT Objectives: To study the characteristics of Systemic Lupus Erythematosus in Jordan and

More information

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer

More information

Systemic forms of stiffness

Systemic forms of stiffness Systemic forms of stiffness ANNA LITWIC CONSULTANT RHEUMATOLOGIST SALISBURY DISTRICT HOSPITAL CLINICAL RESEARCH FELLOW MRC LIFECOURSE EPIDEMIOLOGY UNIT Overview Rheumatoid arthritis Know it when you see

More information

Conflict of Interest. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital.

Conflict of Interest. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital Conflict of Interest Disclosures: None Overview Diagnostic Classification Criteria of SLE

More information

Rheumatology Primer: What Labs and When

Rheumatology Primer: What Labs and When Rheumatology Primer: What Labs and When Irina Konon, MD Department of Internal Medicine Division of Rheumatology Medical College of Wisconsin Disclosures None 1 Objective Discuss principles of laboratory

More information

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus? Lupus Systemic lupus erythematosus, referred to as SLE or lupus, is sometimes called the "great imitator." Why? Because of its wide range of symptoms, people often confuse lupus with other health problems.

More information

Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology

Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Eugene Rheumatology Financial Relationships Amgen Genentech AbbVie IS THIS LUPUS? S.T. is a 45 y/o woman with 9 months of joint pain, fatigue,

More information

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may

More information

SLE and the Antiphospholipid Syndrome

SLE and the Antiphospholipid Syndrome SLE and the Antiphospholipid Syndrome Susan Y. Ritter MD, PhD Associate Physician Division of Rheumatology, Immunology and Allergy Department of Medicine Brigham and Women s Hospital Instructor in Medicine

More information

Rheumatoid Arthritis

Rheumatoid Arthritis Rheumatoid Arthritis Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly

More information

AUTOIMMUNITY CLINICAL CORRELATES

AUTOIMMUNITY CLINICAL CORRELATES AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel

More information

AUTOIMMUNITY TOLERANCE TO SELF

AUTOIMMUNITY TOLERANCE TO SELF AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel

More information

ERROR CORRECTION FORM

ERROR CORRECTION FORM Juvenile Idiopathic Arthritis Pre-HSCT Data Sequence Number: Registry Use Only Date of HSCT for which this form is being completed: HSCT type: autologous allogeneic, allogeneic, syngeneic unrelated related

More information

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed:

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: Juvenile Idiopathic Arthritis Pre-HSCT Data Sequence Number: Date Received: Registry Use Only Today s Date: Date of HSCT for which this form is being completed: HSCT type: autologous allogeneic, allogeneic,

More information

The Rheumatoid Hand Deformities & Management. Dr. Anirudh Sharma Resident Department of Orthopedics

The Rheumatoid Hand Deformities & Management. Dr. Anirudh Sharma Resident Department of Orthopedics + The Rheumatoid Hand Deformities & Management Dr. Anirudh Sharma Resident Department of Orthopedics + Why is Rheumatoid Arthritis important? + RA is a very debilitating disease median life expectancy

More information

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: &

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: & Systemic Lupus Erythematosus Pre-HSCT Data Sequence Number: Date Received: Registry Use Only Today s Date: Date of HSCT for which this form is being completed: & HSCT type: o autologous o allogeneic, o

More information

New Onset Arthritis. Clinical Dilemmas in Arthritis and Rheumatology. Physical Examination. Other Pertinent History

New Onset Arthritis. Clinical Dilemmas in Arthritis and Rheumatology. Physical Examination. Other Pertinent History New Onset Arthritis Clinical Dilemmas in Arthritis and Rheumatology Primary Care Principles and Practice October 2008 Jonathan Graf, MD Assistant Professor of Medicine, UCSF Division of Rheumatology, SFGH

More information

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus A Patient s Guide to Systemic Lupus Erythematosus 2 kidneys. These changes make it impossible for the kidneys to function normally. The inflammation of SLE can be seen in the lining, covering, and muscles

More information

Requirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope

Requirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope + T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +

More information

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS Introduction: There is perhaps no rheumatic disease that evokes so much fear and confusion among both patients

More information

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens: Autoimmunity Reactivity to self antigens: Autoreactivity: Autoimmune Disease T cells B cells Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection Epidemiology SLE Pathogenesis

More information

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS Only valid for adult patients Azathioprine must be at a dose of at least

More information

Autoimmunity. Autoimmune Disease

Autoimmunity. Autoimmune Disease Autoimmunity Reactivity to self antigens: T cells B cells Autoimmune Disease Autoreactivity: Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection 1 SLE Pathogenesis Immune

More information

Following the bite of a mosquito infected with CHIKV, most individuals will

Following the bite of a mosquito infected with CHIKV, most individuals will 3. CLINICAL 3A. Clinical Presentation of Acute Disease Following the bite of a mosquito infected with CHIKV, most individuals will present with symptomatic disease after an incubation period of 3-7 days

More information

The Diagnosis of Lupus

The Diagnosis of Lupus The Diagnosis of Lupus LUPUSUK 2017 This information booklet has been produced by LUPUS UK 2017 LUPUS UK LUPUS UK is the registered national charity for people with systemic lupus erythematosus (SLE) and

More information

How do polyarthritis, polyarthralgias, and diffuse aches and pains differ?

How do polyarthritis, polyarthralgias, and diffuse aches and pains differ? Approach to the patient with polyarthritis How do polyarthritis, polyarthralgias, and diffuse aches and pains differ? Polyarthritis is definite inflammation (swelling, tenderness, warmth) of more than

More information

Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital

Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital Acknowledgements: KKCTH Dr. Ramkumar Consultant Dermatologist Dr. Ramprakash Consultant Ophthalmologist Dr. Prasad Manne

More information

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J. Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis

More information

CSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction

CSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction CSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction Setting: ER Mr. Smith I ve just felt so weak for so long, and I ve lost so much weight, and now I m having trouble breathing it s affecting

More information

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation Marcelo C. Pasquini, MD, MSc HVD05_1.ppt Outline Review of autoimmune diseases (AID). Role of transplantation for AID Data collection:

More information

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z Topic Page: Systemic Lupus Erythematosus Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z What Is It? Lupus is thought to develop when the immune system

More information

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed

More information

Acute Emergencies in Rheumatology

Acute Emergencies in Rheumatology Acute Emergencies in Rheumatology Clare Higgens Northwick Park hospital and St George s Hospital London Acute Rheumatological Emergencies The Acute Hot joint Inflammatory back pain.. Systemic lupus erythematosus(sle)

More information

Policy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:

Policy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject: Last Review Status/Date: December 2014 Page: 1 of 10 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present

More information

1.0 Abstract. Title. Keywords. Rationale and Background

1.0 Abstract. Title. Keywords. Rationale and Background 1.0 Abstract Title A Prospective, Multi-Center Study in Rheumatoid Arthritis Patients on Adalimumab to Evaluate its Effect on Synovitis Using Ultrasonography in an Egyptian Population Keywords Synovitis

More information

Hths 2231 Laboratory 13 Alterations in Musculoskeletal

Hths 2231 Laboratory 13 Alterations in Musculoskeletal Watch Movie: Osteoporosis Answer the movie questions on the worksheet. Complete activities 1-4. Activity #1: Click on the website link in activity 1 to review the structure and function of bone. Activity

More information

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 Jeopardy Antibodies & more antibodies Aching joints What s the rash? Potpourri Image Challenge $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500

More information

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Is it Autoimmune or NOT! Presented to AONP! October 2015! Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells

More information

Rheumatology 101 A Pediatrician s Guide

Rheumatology 101 A Pediatrician s Guide Rheumatology 101 A Pediatrician s Guide Pediatric Staff and Alumni Day 2016 Dawn M. Wahezi, Yonit Sterba, Tamar Rubinstein Disclosures None Pick a Group Group 1 A child with a limp Group 2 ANA To test

More information

A Patient s Guide to Psoriatic Arthritis

A Patient s Guide to Psoriatic Arthritis A Patient s Guide to Psoriatic Arthritis Glendale Adventist Medical Center 1509 Wilson Terrace Glendale, CA 91206 Phone: (818) 409-8000 DISCLAIMER: The information in this booklet is compiled from a variety

More information

A Patient s Guide to Rheumatoid Arthritis

A Patient s Guide to Rheumatoid Arthritis A Patient s Guide to Rheumatoid Arthritis 651 Old Country Road Plainview, NY 11803 Phone: 5166818822 Fax: 5166813332 p.lettieri@aol.com DISCLAIMER: The information in this booklet is compiled from a variety

More information

The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy

The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy Learning Objectives When to use an acute rheumatology service Appropriate use of steroids by condition Injection or Oral or Intramuscular

More information

Lupus as a risk factor for cardiovascular disease

Lupus as a risk factor for cardiovascular disease Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo

More information

Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria

Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Farjah H AlGahtani Associate professor,md,mph Leukemia,Lymphoma in adolescent,thromboembolic

More information

1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout

1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout Objectives 1. To review the diagnosis of gout and its differential GOUT 2. To understand the four stages of gout 3. To develop an approach for the acute treatment of gout Anthony Lim 9/13/12 Cycle 3 4.

More information

Juvenile Idiopathic Arthritis (JIA)

Juvenile Idiopathic Arthritis (JIA) Juvenile Idiopathic Arthritis (JIA) Kaveh Ardalan, MD, MS Division of Rheumatology Ann & Robert H. Lurie Children s Hospital of Chicago Assistant Professor, Pediatrics and Medical Social Sciences Northwestern

More information

Amino acid sequences in the β chain HLA- DRB*0401 molecules dictate susceptibility to RA Amino Acids in the Shared Epitope

Amino acid sequences in the β chain HLA- DRB*0401 molecules dictate susceptibility to RA Amino Acids in the Shared Epitope MHC/self-peptide MHC/Vβ TCR Vβx + Vβx T cell Induction of + TH1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and APC type I diabetes TCR Vβx Activated

More information

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases Editing file Color code: Important in red Extra in blue Autoimmune Diseases Objectives To know that the inflammatory processes in autoimmune diseases are mediated by hypersensitivity reactions (type II,

More information

How to interpret and order rheumatology tests

How to interpret and order rheumatology tests How to interpret and order rheumatology tests Kam Shojania, MD, FRCPC Clinical Professor and Head, UBC Division of Rheumatology Faculty/Presenter Disclosure Faculty: Kam Shojania Relationships with financial

More information

Lupus and Friends Perspectives on common syndromes and Primary care responses

Lupus and Friends Perspectives on common syndromes and Primary care responses Lupus and Friends Perspectives on common syndromes and Primary care responses Paul H Caldron DO, PhD, FACP, FACR, MBA Arizona Arthritis and Rheumatology Associates, PC University of Arizona College of

More information

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH Emergent Rheumatologic Diseases and Disorders for Primary Care. The Power of the ANA April 2018 Emily Littlejohn, DO MPH Question 1: the ANA test is: A) A screening test with high specificity to diagnose

More information

To live with lupus, we need to know about lupus.

To live with lupus, we need to know about lupus. To live with lupus, we need to know about lupus. Zineb Aouhab, MD Assistant Professor of Medicine Loyola University Medical Center Division of Rheumatology 1 Where did the word lupus come from? The word

More information

Systemic lupus erythematosus in a male patient

Systemic lupus erythematosus in a male patient IOP Conference Series: Earth and Environmental Science PAPER OPEN ACCESS Systemic lupus erythematosus in a male patient To cite this article: H Sibarani and Z Zubir 2018 IOP Conf. Ser.: Earth Environ.

More information

Fever of unknown origin

Fever of unknown origin Fever of unknown origin Case B History of the present illness 75 years old women presented at our hospital with since months daily fevers between 38 to 39.5 Celsius (100.4-103.1 F) with night sweats. Her

More information

JuvenileIdiopathicArthritis. Dr Johan Siebert

JuvenileIdiopathicArthritis. Dr Johan Siebert JuvenileIdiopathicArthritis Dr Johan Siebert 1 NORMAL DIARTHRODIAL JOINT Synovial is a thin membrane enclosing the joint space The joint space contains fluid that bathes the joint and reduces friction

More information

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) Rheumatoid Arthritis Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) 503-6999. 1 Disclosures Speaker Bureau: Abbvie 2 Objectives Better understand the pathophysiology

More information

Rheumatic heart disease

Rheumatic heart disease Rheumatic heart disease What will we discuss today? Etiology and epidemiology of rheumatic heart disease Pathogenesis of rheumatic heart disease Morphological changes in rheumatic heart disease Clinical

More information

PS + MPs PS - MPs 37% 36% 64% 64%

PS + MPs PS - MPs 37% 36% 64% 64% Supplementary Figure 1. Amount and distribution of phosphatidylserine negative (PS - ) and phosphatidylserine positive (PS + ) MPs in 280 SLE patients and 280 controls. Circles are proportional to the

More information

IMACS FORM 07b: MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL, Version

IMACS FORM 07b: MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL, Version IMACS FORM 07b: MYOSITIS ASSESSMENT TOOL, Version 2 2005 Subject s IMACS number: ASSESSOR: Date Assessed: Assessment number: The clinical features recorded are based upon the previous 4 weeks and the judgment

More information

IMMUNE DISORDER. Reference:-Pathophysiology: A 2-in-1 Reference for Nurses. Philadelphia, PA, USA: LWW (PE), 2004.

IMMUNE DISORDER. Reference:-Pathophysiology: A 2-in-1 Reference for Nurses. Philadelphia, PA, USA: LWW (PE), 2004. IMMUNE DISORDER Reference:-Pathophysiology: A 2-in-1 Reference for Nurses. Philadelphia, PA, USA: LWW (PE), 2004. Immune system disorders Hypersensitivity is an exaggerated or inappropriate response that

More information

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Directions: Each of the numbered items or incomplete statements in this section is followed by answers or by completions of the statement.

More information

Systemic lupus erythematosus (SLE) ... PRESENTATIONS... Epidemiology of Systemic Lupus Erythematosus. Based on a presentation by Susan Manzi, MD, MPH

Systemic lupus erythematosus (SLE) ... PRESENTATIONS... Epidemiology of Systemic Lupus Erythematosus. Based on a presentation by Susan Manzi, MD, MPH ... PRESENTATIONS... Epidemiology of Systemic Lupus Erythematosus Based on a presentation by Susan Manzi, MD, MPH Presentation Summary Tracking the epidemiology of systemic lupus erythematosus is problematic

More information

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases Introduction to Training Cases The purpose of this preliminary exercise is to familiarize you with the rules and logistics of the five instruments under study. Please do not read the Training Cases until

More information

10/6/08. Systemic Lupus Erythematosus. SLE Epidemiology: who is at risk? Margrit Wiesendanger Division of Rheumatology, CUMC.

10/6/08. Systemic Lupus Erythematosus. SLE Epidemiology: who is at risk? Margrit Wiesendanger Division of Rheumatology, CUMC. Systemic Lupus Erythematosus SLE Epidemiology: who is at risk? One of the most common autoimmune diseases affecting women of all ages Predominantly women in child-bearing years (M:F ratio is 1:10) Incidence

More information